New developments in the pharmacological management of prostate cancer

被引:6
作者
Fitzpatrick, JM [1 ]
机构
[1] Univ Coll Dublin, Mater Misericordiae Hosp, Professorial Surg Unit, Dept Surg, Dublin 7, Ireland
关键词
D O I
10.1046/j.1464-410X.2000.00064.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:31 / 37
页数:7
相关论文
共 38 条
[1]   What's hot in the prostate? [J].
Belldegrun, A .
PROSTATE CANCER AND PROSTATIC DISEASES, 1999, 2 (01) :1-2
[2]  
Butler EB, 1997, SEMIN SURG ONCOL, V13, P406, DOI 10.1002/(SICI)1098-2388(199711/12)13:6<406::AID-SSU4>3.0.CO
[3]  
2-E
[4]   DETECTION OF ORGAN-CONFINED PROSTATE-CANCER IS INCREASED THROUGH PROSTATE-SPECIFIC ANTIGEN-BASED SCREENING [J].
CATALONA, WJ ;
SMITH, DS ;
RATLIFF, TL ;
BASLER, JW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (08) :948-954
[5]  
Cole P, 1996, CANCER, V78, P2045, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2045::AID-CNCR3>3.0.CO
[6]  
2-N
[7]   Overview: Hormone refractory prostate cancer [J].
Crawford, ED ;
Rosenblum, M ;
Ziada, AM ;
Lange, PH .
UROLOGY, 1999, 54 (6A) :1-7
[8]  
DALESIO O, 1995, LANCET, V346, P265
[9]  
EISENBERGER MA, 1994, SEMIN ONCOL, V21, P613
[10]   DESIGN OF THE PROSTATE-CANCER PREVENTION TRIAL (PCPT) [J].
FEIGL, P ;
BLUMENSTEIN, B ;
THOMPSON, I ;
CROWLEY, J ;
WOLF, M ;
KRAMER, BS ;
COLTMAN, CA ;
BRAWLEY, OW ;
FORD, LG .
CONTROLLED CLINICAL TRIALS, 1995, 16 (03) :150-163